Pleiotropy HDWAS

HDWAS Prescribing in Taiwan graph info

Insight

Reduction of Tubercolusis 肺結核 in Taiwan

2025 04 27 Owen Yang

The 2023 Taiwan Tuberculosis Control Report, the Tuberculosis incidence rate in Taiwan has decreased from 72.5 cases per 100,000 population in 2005 to 28.2 cases in 2023. This is also reflected in the reduction of Single (#J04AK) and Combination (#J04AM) Drugs for Tuberculosis in Prescribing in Taiwan.

Go to all insights

All ATC codes in this group and OTC availability

J04AM02	rifampicin and isoniazid	not available OTC
J04AM03	ethambutol and isoniazid	not available OTC
J04AM05	rifampicin, pyrazinamide and isoniazid	not available OTC
J04AM06	rifampicin, pyrazinamide, ethambutol and isoniazid	not available OTC
J04AM07	rifampicin, ethambutol and isoniazid	not available OTC

Prescribing in Taiwan: prescribing rates

Esc to clear search bar

Search results for

J04AM Drugs for Tuberculosis (TB), combinations (Oral)

Prescribing rates 10-year risk of death

Prescribing rates

Insight

Reduction of Tubercolusis 肺結核 in Taiwan

HDWAS Projects